Matches in SemOpenAlex for { <https://semopenalex.org/work/W2680492778> ?p ?o ?g. }
- W2680492778 endingPage "992" @default.
- W2680492778 startingPage "982" @default.
- W2680492778 abstract "Physical activity (PA) is inversely associated with adverse cardiovascular outcomes in healthy populations, but the impact of physical activity in patients with heart failure (HF) with preserved ejection fraction is less well characterized.The baseline self-reported PA of 1751 subjects enrolled in the Americas region of the TOPCAT trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) was categorized as poor, intermediate, or ideal PA with American Heart Association criteria. PA was related to the primary composite outcome (HF hospitalization, cardiovascular mortality, or aborted cardiac arrest), its components, and all-cause mortality with the use of multivariable Cox models.The mean age at enrollment was 68.6±9.6 years. Few patients met American Heart Association criteria for ideal activity (11% ideal, 14% intermediate, 75% poor). Over a median follow-up of 2.4 years, the primary composite outcome occurred in 519 patients (397 HF hospitalizations, 222 cardiovascular deaths, and 6 aborted cardiac arrests). Compared with those with ideal baseline PA, poor and intermediate baseline PA was associated with a greater risk of the primary outcome (hazard ratio [HR], 2.05; 95% confidence interval [CI], 1.28-3.28; HR, 1.95; 95% CI, 1.15-3.33, respectively), HF hospitalization (HR, 1.93; 95% CI, 1.16-3.22; HR, 1.84; 95% CI, 1.02-3.31), cardiovascular mortality (HR, 4.36; 95% CI, 1.37-13.83; HR, 4.05; 95% CI, 1.17-14.04), and all-cause mortality (HR, 2.95; 95% CI, 1.44-6.02; HR, 2.05; 95% CI, 0.90-4.67) after multivariable adjustment for potential confounders.In patients with HF with preserved ejection fraction, both poor and intermediate self-reported PA were associated with higher risk of HF hospitalization and mortality.URL: https://clinicaltrials.gov. Unique identifier: NCT00094302." @default.
- W2680492778 created "2017-06-30" @default.
- W2680492778 creator A5005215114 @default.
- W2680492778 creator A5010456790 @default.
- W2680492778 creator A5025056096 @default.
- W2680492778 creator A5031560506 @default.
- W2680492778 creator A5038371805 @default.
- W2680492778 creator A5042843111 @default.
- W2680492778 creator A5054830306 @default.
- W2680492778 creator A5066172646 @default.
- W2680492778 creator A5081238407 @default.
- W2680492778 creator A5086850743 @default.
- W2680492778 creator A5086876634 @default.
- W2680492778 date "2017-09-12" @default.
- W2680492778 modified "2023-09-26" @default.
- W2680492778 title "Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist)" @default.
- W2680492778 cites W113644040 @default.
- W2680492778 cites W1511208491 @default.
- W2680492778 cites W1560674024 @default.
- W2680492778 cites W1574276266 @default.
- W2680492778 cites W1777630920 @default.
- W2680492778 cites W1818378016 @default.
- W2680492778 cites W1967405452 @default.
- W2680492778 cites W1970705375 @default.
- W2680492778 cites W1972139477 @default.
- W2680492778 cites W1974950104 @default.
- W2680492778 cites W1977247044 @default.
- W2680492778 cites W2005238372 @default.
- W2680492778 cites W2005944863 @default.
- W2680492778 cites W2006327784 @default.
- W2680492778 cites W2028139057 @default.
- W2680492778 cites W2048717272 @default.
- W2680492778 cites W2049452504 @default.
- W2680492778 cites W2053876822 @default.
- W2680492778 cites W2068519950 @default.
- W2680492778 cites W2069966017 @default.
- W2680492778 cites W2084254617 @default.
- W2680492778 cites W2095863612 @default.
- W2680492778 cites W2099988884 @default.
- W2680492778 cites W2104209472 @default.
- W2680492778 cites W2104431466 @default.
- W2680492778 cites W2111692794 @default.
- W2680492778 cites W2112446953 @default.
- W2680492778 cites W2113829060 @default.
- W2680492778 cites W2114109157 @default.
- W2680492778 cites W2116247729 @default.
- W2680492778 cites W2118634943 @default.
- W2680492778 cites W2126161317 @default.
- W2680492778 cites W2127254785 @default.
- W2680492778 cites W2127712541 @default.
- W2680492778 cites W2137716575 @default.
- W2680492778 cites W2137784332 @default.
- W2680492778 cites W2139841046 @default.
- W2680492778 cites W2141063224 @default.
- W2680492778 cites W2144852094 @default.
- W2680492778 cites W2152072062 @default.
- W2680492778 cites W2154395080 @default.
- W2680492778 cites W2166504467 @default.
- W2680492778 cites W2330716957 @default.
- W2680492778 cites W2340801761 @default.
- W2680492778 cites W2475261460 @default.
- W2680492778 cites W2539412725 @default.
- W2680492778 cites W2546778110 @default.
- W2680492778 cites W2548447630 @default.
- W2680492778 cites W2605975631 @default.
- W2680492778 cites W2727980964 @default.
- W2680492778 cites W34051893 @default.
- W2680492778 doi "https://doi.org/10.1161/circulationaha.117.028002" @default.
- W2680492778 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6592611" @default.
- W2680492778 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28637881" @default.
- W2680492778 hasPublicationYear "2017" @default.
- W2680492778 type Work @default.
- W2680492778 sameAs 2680492778 @default.
- W2680492778 citedByCount "79" @default.
- W2680492778 countsByYear W26804927782017 @default.
- W2680492778 countsByYear W26804927782018 @default.
- W2680492778 countsByYear W26804927782019 @default.
- W2680492778 countsByYear W26804927782020 @default.
- W2680492778 countsByYear W26804927782021 @default.
- W2680492778 countsByYear W26804927782022 @default.
- W2680492778 countsByYear W26804927782023 @default.
- W2680492778 crossrefType "journal-article" @default.
- W2680492778 hasAuthorship W2680492778A5005215114 @default.
- W2680492778 hasAuthorship W2680492778A5010456790 @default.
- W2680492778 hasAuthorship W2680492778A5025056096 @default.
- W2680492778 hasAuthorship W2680492778A5031560506 @default.
- W2680492778 hasAuthorship W2680492778A5038371805 @default.
- W2680492778 hasAuthorship W2680492778A5042843111 @default.
- W2680492778 hasAuthorship W2680492778A5054830306 @default.
- W2680492778 hasAuthorship W2680492778A5066172646 @default.
- W2680492778 hasAuthorship W2680492778A5081238407 @default.
- W2680492778 hasAuthorship W2680492778A5086850743 @default.
- W2680492778 hasAuthorship W2680492778A5086876634 @default.
- W2680492778 hasBestOaLocation W26804927781 @default.
- W2680492778 hasConcept C111566952 @default.
- W2680492778 hasConcept C126322002 @default.
- W2680492778 hasConcept C164705383 @default.
- W2680492778 hasConcept C207103383 @default.